Tag: GCP compliance

Documenting Quality Agreements & SOWs for Audits, Health Authority Queries and Due Diligence Documenting Quality Agreements & SOWs for Audits, Health Authority Queries and Due Diligence In the realm of clinical research, particularly within the domains governed by the FDA in the United States, the EMA in Europe, and the MHRA in the United Kingdom,…

Read More “Documenting Quality Agreements & SOWs for Audits, Health Authority Queries and Due Diligence” »

Digital Tools and Automation That Transform Quality Agreements & SOWs in Clinical Development As clinical trials evolve in complexity and scope, the importance of robust quality agreements (QAs) and statements of work (SOWs) becomes increasingly clear. Both documents play critical roles in ensuring compliance, accountability, and clarity in agreements between sponsors and service providers. Digital…

Read More “Digital Tools and Automation That Transform Quality Agreements & SOWs in Clinical Development” »

Case Studies: Quality Agreements & SOWs That Rescued High-Risk Studies and Vendors In the landscape of clinical trials, particularly in high-risk environments, robust frameworks to govern relationships between organizations are critical. This article serves as a step-by-step guide for clinical operations, regulatory affairs, and medical affairs professionals focusing on quality agreements and Statements of Work…

Read More “Case Studies: Quality Agreements & SOWs That Rescued High-Risk Studies and Vendors” »

Integrating Quality Agreements & SOWs With QMS, Risk Registers and Governance Committees Integrating Quality Agreements & SOWs With QMS, Risk Registers and Governance Committees The clinical trial landscape has rapidly evolved, necessitating enhanced oversight to ensure compliance and efficiency. Quality Agreements (QAs) and Statements of Work (SOWs) play a critical role in defining the expectations…

Read More “Integrating Quality Agreements & SOWs With QMS, Risk Registers and Governance Committees” »

Future-Proofing Quality Agreements & SOWs for AI, Real-World Data and Platform Trials Future-Proofing Quality Agreements & SOWs for AI, Real-World Data and Platform Trials The integration of artificial intelligence, real-world data, and platform trials into clinical research has transformed the landscape of drug development. These advancements demand an evolution of traditional quality agreements and statements…

Read More “Future-Proofing Quality Agreements & SOWs for AI, Real-World Data and Platform Trials” »

Aligning Quality Agreements & SOWs With ICH E6(R3), GCP and Quality-by-Design Principles Aligning Quality Agreements & SOWs With ICH E6(R3), GCP and Quality-by-Design Principles Introduction to Quality Agreements and SOWs in Clinical Trials The implementation of clinical trials is a complex endeavor requiring strict adherence to guidelines and regulations. Central to this process are Quality…

Read More “Aligning Quality Agreements & SOWs With ICH E6(R3), GCP and Quality-by-Design Principles” »

Quality Agreements & SOWs Checklists for Clinical Operations and Vendor Governance Teams In the landscape of clinical operations, the management of quality agreements and Statements of Work (SOWs) stands as a critical component in ensuring compliance and efficiency. This comprehensive guide provides clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and…

Read More “Quality Agreements & SOWs Checklists for Clinical Operations and Vendor Governance Teams” »

Common Pitfalls in Quality Agreements & SOWs—and How to Avoid Regulatory Findings Common Pitfalls in Quality Agreements & SOWs—and How to Avoid Regulatory Findings Quality agreements and Statements of Work (SOWs) are critical components in the successful execution of clinical trials, including prominent studies such as the destiny breast04 clinical trial. These documents not only…

Read More “Common Pitfalls in Quality Agreements & SOWs—and How to Avoid Regulatory Findings” »